Chemistry:AP-238
From HandWiki
Short description: Opioid designer drug
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H26N2O |
| Molar mass | 286.419 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
AP-238 is an opioid designer drug related to drugs such as azaprocin and bucinnazine, with around the same potency as morphine.[2] It was first discovered in Italy in the 1960s but was never marketed,[3] subsequently appearing on the illicit market around 2020 and being detected in both Slovenia and the USA.[4][5]
See also
- 2F-Viminol
- Diphenpipenol
- Dipyanone
- Etodesnitazene
- MT-45
- Nortilidine
- O-AMKD
- O-DSMT
- Piperidylthiambutene
- SHR9352
References
- ↑ "2-Methyl-AP-237". U.S Drug Enforcement Administration. https://deadiversion.usdoj.gov/drug_chem_info/2-Methyl-AP-237.pdf.
- ↑ "Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238". Archives of Toxicology 96 (6): 1701–1710. June 2022. doi:10.1007/s00204-022-03257-7. PMID 35275255.
- ↑ "2,6-Dialkylpiperazines. IV. 1-Propionyl-4-substituted cis-2,6-dimethylpiperazines structurally related to the analgetic 8-acyl-3,8-diazabicyclo[3.2.1]octanes". Journal of Medicinal Chemistry 11 (3): 592–594. May 1968. doi:10.1021/jm00309a039. PMID 5656502.
- ↑ {{cite web | url = https://www.policija.si/apps/nfl_response_web/0_Analytical_Reports_final/AP-238-ID-2185-20_report.pdf | title = Analytical Report. AP-238. 1-{2,6‐dimethyl‐4‐[(2E)‐3‐phenylprop‐2‐en‐1‐yl]piperazin‐1‐yl}propan-1-one. | work =Nacionalni Forenzični Laboratorij | date = 20 October 2020 }}
- ↑ "AP-238". NPS Discovery at CFSRE. Center for Forensic Science Research and Education (CFSRE). 11 November 2020. https://www.npsdiscovery.org/wp-content/uploads/2020/11/AP-238_111120_CFSRE-Toxicology_Report.pdf.
 |  |
